Home Journals Articles Updates About
CN
image
收藏切换
The clinical application and development of traditional antitumor drugs
收藏切换
PDF
Jiao XU1, Ling-hua MENG2, Chen QING1, *
Acta Pharmaceutica Sinica | 2021, 56(6) : 1551 - 1561
Less
收藏切换
Acta Pharmaceutica Sinica | 2021, 56(6): 1551-1561
• Reviews •
The clinical application and development of traditional antitumor drugs
Full
Jiao XU1, Ling-hua MENG2, Chen QING1, *
Affiliations
  • 1. Kunming Medical University, Kunming 650500, China
  • 2. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
Published: 2021-06-12 doi: 10.16438/j.0513-4870.2020-1895
Outline
收藏切换

Traditional antitumor drugs are cytotoxic chemotherapeutic drugs that can directly kill tumor cells and inhibit the growth and proliferation of tumor cells. Modern chemotherapy for tumors was initiated by use of nitrogen mustard to treat lymphomas in 1946, which was derived from mustard gas. Starting with nitrogen mustard, many kinds of anti-tumor drugs, including alkylating agents, anti-metabolism drugs, anti-tumor antibiotics, and anti-tumor plant drugs, have been successively developed for clinical treatment. Traditional antitumor drugs are the cornerstone of tumor chemotherapy and play important roles in the comprehensive treatment and neoadjuvant therapy of malignant tumors. In recent years, the combination of traditional antitumor drugs with molecular targeted therapy, immunotherapy, and radiotherapy has greatly improved the survival rate of tumor patients. With the deepening understanding of tumor genome as well as tumor initiation and promotion, the concepts of precision medicine and individualized treatment have been proposed and achieved success in clinical practice. In this context, the strategies leading to personalized therapy with traditional anti-tumor drugs also need to be further studied and optimized. This review summarized the recent clinical application and research progress of traditional antitumor drugs.

traditional antitumor drug  /  personalized therapy  /  targeted therapy  /  immunotherapy  /  radiotherapy  /  combination therapy
Jiao XU, Ling-hua MENG, Chen QING. The clinical application and development of traditional antitumor drugs[J]. Acta Pharmaceutica Sinica, 2021 , 56 (6) : 1551 -1561 . DOI: 10.16438/j.0513-4870.2020-1895
Appendix
Less
Year 2021 volume 56 Issue 6
PDF
195
96
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-1895
  • Receive Date：2020-12-08
  • Online Date：2025-12-18
  • Published：2021-06-12
Article Data
Affiliations
History
  • Received：2020-12-08
  • Revised：2020-12-30
Funding
Affiliations
    1. Kunming Medical University, Kunming 650500, China
    2. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-1895
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House